interpretation of cardiac troponin (cTn). 1,2 Specifically, a decrease in cTn concentration may occur due to stability issues 1 or the presence of an interference (i.e. haemolysis) 2 which may be inappropriately interpreted as a clinically significant change. 3, 4 Thus, it is imperative that preanalytical and analytical factors are documented for each cTn assay such that the laboratory can properly restrict retrospective 'add-on' testing or measurement in samples with interferences present. Recently, Chenevier-Gobeaux et al. 2 have reported on factors affecting analytical performance of highsensitivity cTnT (hs-cTnT); however, stability was not assessed. Surprisingly, limited data exist in this area with respect to freeze-thaw effects on hs-cTnT concentrations or on stability in different matrices, with a report earlier this year indicating that hs-cTnT concentrations are stable up to 24 h at room temperature in serum. 5 Therefore, we performed a study assessing stability and the freeze -thaw effect on hs-cTnT concentrations in different matrices and over different timeframes.
National guidelines for analysis of cerebrospinal fluid for bilirubin in suspected subarachnoid haemorrhage
The revised national guidelines for analysis of cerebrospinal fluid (CSF) for bilirubin in suspected subarachnoid haemorrhage 1 omits reference to the rare occurrence of a falsepositive computerized tomography (CT) brain scan that will likely lead to magnetic resonance angiography or CT angiography depending on local access to technology. Subarachnoid contrast enhancement mimicking subarachnoid haemorrhage has been described. 2, 3 
